# Gossamer Bio

**Source:** https://www.startuphub.ai/startups/gossamer-bio
**Profile type:** Startup

> A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

## About

Gossamer Bio is a clinical-stage biopharmaceutical company focused on developing its investigational drug product, seralutinib, for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Seralutinib is an inhaled inhibitor designed to enhance the lives of people living with these rare diseases. The company is committed to advancing new therapies and supporting patient communities.

## Key facts

- **Slug:** gossamer-bio
- **Website:** https://www.gossamerbio.com/
- **Location:** San Diego, California, USA
- **Founded:** 2017-01-01 00:00:00
- **Employees:** 154
- **Operating status:** Active
- **Total funding:** $150M
- **Sectors / tags:** Biotechnology, Pharmaceuticals, Healthcare, Biotech, MedTech, Drug Discovery, Clinical Trials, Pulmonary Arterial Hypertension
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/gossamer-bio/
  - Twitter: https://twitter.com/GossamerBio

## Frequently asked

### What does Gossamer Bio do?

Gossamer Bio is a clinical-stage biopharmaceutical company focused on developing its investigational drug product, seralutinib, for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Seralutinib is an inhaled inhibitor designed to enhance the lives of people living with these rare diseases. The company is committed to advancing new therapies and supporting patient communities. (formerly [].)

### What is Gossamer Bio's revenue?

StartupHub estimates Gossamer Bio's annual revenue at $14.8M (range $8.5M to $48.1M, 68% confidence), based on comparable companies in the sector.

### What is Gossamer Bio's valuation?

StartupHub estimates Gossamer Bio's effective valuation at $558.3M (range $390.8M to $725.7M, 28% confidence), based on comparable companies in the sector.

### How much funding has Gossamer Bio raised?

Gossamer Bio has raised a total of $150M in funding. The most recent round on record is Series B.

### Where is Gossamer Bio headquartered?

Gossamer Bio is headquartered in San Diego, California, USA.

### When was Gossamer Bio founded?

Gossamer Bio was founded in 2017.

### What industry does Gossamer Bio operate in?

Gossamer Bio operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, MedTech, Drug Discovery.

### How many employees does Gossamer Bio have?

Gossamer Bio has approximately 154 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Gossamer Bio",
          "item": "https://www.startuphub.ai/startups/gossamer-bio"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/gossamer-bio#webpage",
      "url": "https://www.startuphub.ai/startups/gossamer-bio",
      "name": "Gossamer Bio - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Gossamer Bio (formerly []). Gossamer Bio is a startup founded in 2017, operating in Biotechnology and Pharmaceuticals. A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension. Headquartered in San Diego, California, USA. The company has approximately 154 employees.",
      "dateModified": "2026-07-07T14:52:50.374285+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/gossamer-bio#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/gossamer-bio#organization",
      "name": "Gossamer Bio",
      "url": "https://www.gossamerbio.com/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/b9e09024-a57a-42c9-b1a2-17d4078c650f-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/b9e09024-a57a-42c9-b1a2-17d4078c650f-square.webp",
      "description": "This is the official profile of Gossamer Bio (formerly []). Gossamer Bio is a startup founded in 2017, operating in Biotechnology and Pharmaceuticals. A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension. Headquartered in San Diego, California, USA. The company has approximately 154 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/gossamer-bio/",
        "https://twitter.com/GossamerBio",
        "https://www.startuphub.ai/startups/gossamer-bio"
      ],
      "foundingDate": "2017-01-01 00:00:00",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 154
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "San Diego",
        "addressRegion": "California",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotechnology",
        "Pharmaceuticals",
        "Healthcare",
        "Biotech",
        "MedTech",
        "Drug Discovery",
        "Clinical Trials",
        "Pulmonary Arterial Hypertension"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/gossamer-bio#profile-assessment",
      "name": "Gossamer Bio - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/gossamer-bio",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/b9e09024-a57a-42c9-b1a2-17d4078c650f-square.webp",
      "category": "Biotechnology",
      "description": "This is the official profile of Gossamer Bio (formerly []). Gossamer Bio is a startup founded in 2017, operating in Biotechnology and Pharmaceuticals. A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension. Headquartered in San Diego, California, USA. The company has approximately 154 employees.",
      "brand": {
        "@type": "Brand",
        "name": "Gossamer Bio"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-07-07",
        "name": "Gossamer Bio - Profile Score 53/100",
        "reviewBody": "This is the official profile of Gossamer Bio (formerly []). Gossamer Bio is a startup founded in 2017, operating in Biotechnology and Pharmaceuticals. A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension. Headquartered in San Diego, California, USA. The company has approximately 154 employees.",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 53,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```